LONDON - A reliance on vaccines in short supply and questions over their best use are hampering efforts to curb the global spread of monkeypox which has hit dozens of countries for the first time, health officials say.
Other experts say an equitable global response would also prioritise an undetermined number of high-risk people in the 11 countries in Africa where monkeypox has been a public health problem for years. Dr Ogoina's research in 2017 highlighted possible sexual transmission of monkeypox in Nigeria - where no vaccines are, or have been, available.
"The first control strategy is behaviour change: Asking people at high risk to reduce activities that are high risk, such as anonymous hook-ups and/or sex parties, and to adopt behaviours that may reduce risk, such as use of condoms, screening of your body for rash and for your sex partners' bodies for rash before sex," said Dr Jay Varma, director of the Cornell Centre for Pandemic Prevention and Response in the US.
Bavarian Nordic expects in-house capacity to treble by the end of 2022 from what it was in May - and is also in conversations with multiple other companies to expand manufacturing capacity, the spokesman added.Britain, Canada, and Germany are administering one dose per person instead of two, which allows them to inoculate more people even if they each may receive less or less durable protection.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »